Connecticut Law Imposes New Requirements On Pharmaceutical M

Public Act No. 23-171: An Act Protecting Patients and Prohibiting Unnecessary Health Care Costs (Act) took effect in Connecticut on October 1, 2023. Under the Act...

Related Keywords

United States , Connecticut , Washington , Chicago , Illinois , , Connecticut Department , Public Health , Department Of Consumer Protection , Unnecessary Health Care Costs , Consumer Protection Department , Takeda Pharmaceuticals , Public Act , Prohibiting Unnecessary Health Care Costs , Consumer Protection , Under Connecticut , Reporting Requirements , Wholesale Acquisition Cost , Connecticut Prescribers , Mondaq , Connecticut Law Imposes New Requirements On Pharmaceutical Manufacturers , Efined To Include Device And Cosmetic Manufacturers , Hat Employ Quot Pharmaceutical Sales Representatives , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law ,